September 19, 2023
COVID-19 testing company Lucira Health Inc. received approval Tuesday from a Delaware bankruptcy judge to liquidate its remaining assets in Chapter 11 after the company struck a $36.4 million deal in April to sell its business to Pfizer Inc.
April 04, 2023
A Delaware bankruptcy judge denied a request by COVID-19 testing firm Lucira Health Inc. to protect future tax credits by blocking a shareholder from selling its stock, saying Tuesday that the stay imposed by Lucira's Chapter 11 can't interfere with the shareholder's property rights.
February 24, 2023
Bankrupt COVID-19 testing firm Lucira Health Inc. made an initial appearance Friday in Delaware court, telling the court that it is seeking to complete a fast-paced sale process for its assets with bids due by early April.
February 22, 2023
COVID-19 test maker Lucira Health Inc. filed for Chapter 11 protection in Delaware federal bankruptcy court on Wednesday, listing its liabilities as between $50 million and $100 million and saying that it plans to sell its business amid lower demand for tests and slower-than-anticipated regulatory approval.